Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Melanie Bahlo was supported by an Australian National Health and Medical Research Council (NHMRC) Fellowship (GNT 1102971). Brendan Ansell was supported by an NHMRC Early Career Fellowship (GNT 1157776). Roberto Bonelli was supported by a Melbourne International Research Scholarship and the John and Patricia Farrant Foundation. This work was also supported by the Victorian Governments Operational Infrastructure Support Program and the NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The MacTel Project consortium recruited cases and controls at 24 participating clinical centers in seven countries (Australia, Germany, France, UK, Switzerland, Israel and United States). Informed written consent was obtained in accordance with ethics protocols for human subjects approved by the appropriate governing body at each site in accordance with the Declaration of Helsinki. Protocols and records of consent were centrally managed by the EMMES Corporation. The following ethics boards granted approval for human subject enrollment: Quinze-Vingts, Paris, France: Comité de Protection des Personnes Hôpital Saint-Antonie; Centre for Eye Research, Victoria, Australia: The Royal Victorian Eye and Ear Hospital; QIMR Berghofer Institute of Medical Research, Queensland, Australia; Clinique Ophtalmolgie de Creteil, Paris, France: Comité de Protection des Personnes Hôpital Saint-Antonie; Hospital Lariboisiere, Paris, France: Comité de Protection des Personnes Hôpital Saint Antonie; Jules Stein Eye Institute, UCLA, California, USA: The UCLA Institutional Review Board; Lions Eye Institute, Nedlands, Australia: Sire Charles Gairdner Group Human Research Ethics Committee; Manhattan Eye, Ear and Throat Hospital, New York, USA: Lenox Hill Hospital Institutional Review Board; Moorfields Eye Hospital, London, UK: National Research Ethics Service; Retina Associates of Cleveland, Inc., Cleveland, Ohio, USA: Sterling Institutional Review Board; Save Sight Institute, Sydney, Australia: South Eastern Sydney Illawarra Area Health Service Human Research Ethics Committee Northern Hospital Network; Scripps Research Institute, La Jolla, California, USA: Scripps Institutional Review Board; St. Franziskus Hospital, Munster, Germany: Ethik Kommission der Arztekammer Westfalen Lippe und der Medizinishchen Fakultat der Westfallschen Wilhelms Universitat; The Goldschleger Eye Institute, Tel Hashomer, Israel: Ethics Committee The Chaim Sheba Medical Center; The New York Eye and Ear Infirmary, New York, USA: The Institutional Review Board of the New York Eye and Ear Infirmary; The Retina Group of Washington, Olympia, Washington, USA: Western Institutional Review Board; University of Bonn, Bonn, Germany: Rheinische Friedrich Wilhelms Universität Ethik Kommission; University of Chicago, Chicago, Illinois, USA: The University of Chicago Division of Biological Sciences The Pritzker School Institutional Review Board; University of Michigan, Ann Arbor, Michigan, USA: Medical School Institutional Review Board (IRBMED); University of Wisconsin, Madison, Wisconsin, USA: Office of Clinical Trials University of Wisconsin School of Medicine and Public Health; The Wilmer Eye Institute of Johns Hopkins University, Baltimore, Maryland, USA: Johns Hopkins School of Medicine Office of Human Subjects Research; Scheie Eye Institute University of Pennsylvania, Philadelphia, Pennsylvania, USA: University of Pennsylvania Office of Regulatory Affairs; University of Bern, Bern, Switzerland: Kantonale Ethikkommission Bern; John Moran Eye University of Utah, Salt Lake City, Utah, USA: The University of Utah Institutional Review Board; Bascom Palmer Eye Institute University of Miami, Miami, Florida, USA: The University of Miami Human Subjects Research Office; Columbia University, New York, New York, USA: Columbia University Medical Center Institutional Review Board Category 4 waiver for research involving specimens obtained from deidentified subjects.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes